| Acarbose |
|
| (CAS 56180-94-0) |
 |
| Description： |
Acarbose(Bay-g 5421) is an inhibitor of alpha glucosidase, an anti-diabetic drug.
Target: alpha glucosidase
Acarbose is an anti-diabetic drug used to treat type 2 diabetes mellitus and, in some countries, prediabetes. It is an inhibitor of alpha glucosidase, an enteric enzyme that releases glucose from larger carbohydrates.
Acarbose decreased the Fasting Blood Glucose of DM Rats. The fasting blood glucose (FBG) in the acarbose-treated group decreased significantly at week 2 (P<0.05), week 4 (P<0.05), week 6 (P<0.05), and week 8 (P<0.05) compared to the DM group.
Clinical indications: Diabetes mellitus; Glucose intolerance; Hyperglycemia; Non-insulin dependent diabetes
|
| Product No. |
KT20171 |
| Product Name |
Acarbose |
| Synonyms |
Bay-g 5421; BAY g 5421 |
| Formal Name |
|
| CAS Number |
56180-94-0 |
| Molecular Formula |
C25H43NO18 |
| Formula Weight |
645.61 |
| Formulation |
A crystalline solid |
| Purity |
98%min |
| Stability |
2 years |
| Storage |
-20°C |
| Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
| Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
| Price & Availability |
In Stock. Price Negotiated. |
|
| Related Products： |
DTE
DTNB
DTT
Duloxetine
Echinacoside
Edaravone
Eflornithine
Etidronic acid
Etimizol
Exherin
|
|
